New weight loss drug shows promise in early trial
NCT ID NCT06124807
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called Mazdutide to help adults with obesity or overweight lose weight. 179 participants took either the drug or a placebo for about 62 weeks. The main goal was to see how much weight they lost after 32 weeks, with a focus on safety and effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, 98801, United States
-
Charter Research - Lady Lake
The Villages, Florida, 32162, United States
-
Charter Research - Winter Park
Orlando, Florida, 32803, United States
-
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, 66606, United States
-
Dent Neurologic Institute
Amherst, New York, 14226, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, 60640, United States
-
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, 60640, United States
-
Headlands Research - Scottsdale
Scottsdale, Arizona, 85260, United States
-
IMA Clinical Research Austin
Austin, Texas, 78745, United States
-
Knownwell
Needham, Massachusetts, 02492, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
Las Vegas Medical Research
Las Vegas, Nevada, 89128, United States
-
Lucas Research, Inc.
New Bern, North Carolina, 28562, United States
-
North Suffolk Neurology
Port Jefferson Station, New York, 11776, United States
-
Northeast Research Institute (NERI)
Fleming Island, Florida, 32003, United States
-
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, 96817, United States
-
Peninsula Research Associates
Rolling Hills Estates, California, 90274, United States
-
PlanIt Research, PLLC
Houston, Texas, 77079, United States
-
Quality Medical Research
Nashville, Tennessee, 37211, United States
-
Spectrum Medical, Inc.
Danville, Virginia, 24541, United States
-
StudyMetrix Research
City of Saint Peters, Missouri, 63303, United States
-
Suncoast Clinical Research, Inc.
New Port Richey, Florida, 34652, United States
-
Tekton Research - Fredericksburg Road
San Antonio, Texas, 78229, United States
-
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona, 85225, United States
-
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona, 85712, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Huntington Park
Huntington Park, California, 90255, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?